Navigation Links
Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
Date:9/23/2008

- Comprehensive Phase 3 Clinical Program Initiated -

CAMBRIDGE, Mass. and NEW YORK, Sept. 23 /PRNewswire-FirstCall/ -- Ironwood Pharmaceuticals (formerly Microbia) and Forest Laboratories, Inc. (NYSE: FRX) today announced they will present results of a Phase 2b study investigating linaclotide's safety and efficacy in 419 patients with irritable bowel syndrome with constipation (IBS-C) in a plenary session at the American College of Gastroenterology (ACG) 2008 Annual Scientific Meeting in Orlando, Fla. on October 7, 2008. Analysis of these data indicated that the study met its primary endpoint. Linaclotide is a first-in-class investigational compound being evaluated for its potential to treat IBS-C, chronic constipation (CC), and other gastrointestinal disorders.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Ironwood and Forest also announced that they have initiated a comprehensive Phase 3 clinical program to evaluate linaclotide's safety and efficacy in patients with either IBS-C or CC. The program will include two pivotal trials in IBS-C patients and two pivotal trials in CC patients, enrolling over 2,500 patients at approximately 250 clinical centers. The companies recently began patient dosing in the first CC trial and expect to initiate the second CC trial by the end of September, 2008. The companies expect to initiate both IBS-C trials by January, 2009.

IBS-C Phase 2b Study

This U.S. and Canada based, twelve-week, randomized, double-blind, placebo-controlled Phase 2b study was designed to assess the safety, efficacy, and dose-response of linaclotide in patients with IBS-C. Patients were ran
'/>"/>

SOURCE Ironwood Pharmaceuticals; Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
3. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
4. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
5. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
6. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
7. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
8. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
9. ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
10. New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)
11. NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... ISPE—the International Society for Pharmaceutical Engineering ... as President and CEO, succeeding Nancy ... Society last fall.  Mr. Bournas takes the helm ... association industry as well as significant international experience.  ... for the expansion of its global initiatives and ...
(Date:7/29/2014)... (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at ... Lab Expo today by unveiling two booths (#1209 and ... with customers to redefine the value of the laboratory. ... they,re looking for a partner to help them maximize ... said Jack Phillips , president and CEO of ...
(Date:7/29/2014)... , July 29, 2014 Research and ... "Global Respiratory Devices Market 2014-2018" report to their ... A respiratory device is a medical device used ... having difficulty in breathing and cannot achieve adequate oxygen ... as cystic fibrosis, asthma, COPD, and ARDS require the ...
Breaking Medicine Technology:ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Global Respiratory Devices Market 2014-2018 2
... , , TARRYTOWN, N.Y., ... will webcast its presentation at the Deutsche Bank 2009 Biotech ... is scheduled for 3:35 p.m. Eastern Time. The session ... , on the Investor Relations page. An archived version ...
... , MINNEAPOLIS, Dec. 10 Uroplasty, Inc. (NYSE ... develops, manufactures and markets innovative proprietary products to treat ... OrBIT Trial of its Urgent® PC Neuromodulation System that ... of THE JOURNAL OF UROLOGY® . The Urgent ...
Cached Medicine Technology:OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4
(Date:7/29/2014)... 29, 2014) Using quality improvement measures in eight ... Cardiovascular Disease Study Group, researchers have found a way ... with contrast dye. , Currently, 7-15 percent of these ... end up with kidney injury, which can result in ... temporary or permanent dialysis, says a study published in ...
(Date:7/29/2014)... New York (PRWEB) July 29, 2014 ... behalf of individuals who allegedly suffered serious liver ... continue to move forward in a multidistrict litigation ... Pennsylvania, Bernstein Liebhard LLP reports. According to an ... certain deadlines pertaining to bellwether case and ...
(Date:7/29/2014)... By Alan Mozes ... -- Treating certain adult autism patients with just a single ... judge facial expressions and emotions, Japanese researchers report. Known ... a role in emotional bonding between lovers, and between mothers ... neural activity in a key area of the brain that ...
(Date:7/29/2014)... The Law Offices of Michael Cordova is proud ... non-profit organization providing grief camps for kids, teens, adults, and ... our clients experience from the death of a loved one. ... like Stepping Stones of Hope, as they provide hope and ... Hope also includes a monthly support group and a variety ...
(Date:7/29/2014)... receive steady follow-up care, the living donors themselves ... care more accessible, UC San Francisco and Walgreens ... the first program in the country that provides ... kidney donors. , UCSF will provide vouchers for ... Walgreens pharmacies and Healthcare Clinic at select Walgreens ...
Breaking Medicine News(10 mins):Health News:Reducing kidney injury using a quality improvement method 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3Health News:The Law Offices of Michael Cordova is Sponsoring Stepping Stones of Hope, a Non-Profit Organization Providing Grief Camps for Kids, Teens, Adults, and Families 2Health News:Caring for donors 2Health News:Caring for donors 3
... unstoppable, WHO director says; U.S. health officials caution that ... widespread , THURSDAY, June 11 (HealthDay News) -- ... flu pandemic since 1968, triggered by the rapid spread ... America, Europe and regions beyond. , WHO director Dr. ...
... NeuroScience, Inc. has launched an antioxidant protocol that combines ... antioxidant compounds, including OSR#1, CysNAC, and NeuroVitamins. These products ... fat soluble and water soluble areas of the body. ... body,s supply of antioxidants, mainly glutathione, is insufficient to ...
... The National Medical Association (NMA) stands firm in its ... Obama. "AMA,s reservations are duly noted, however, competition is healthy, ... to create the competition that will lead to lower cost ... Barley Britton, president of the National Medical Association. "Public plans ...
... Calif., June 11 As a result of the ... or eliminating bonus payouts in addition to extending cost ... pay trends surveys by Aon Consulting,s Radford, a leading ... sciences industries. , , (Logo: ...
... in the June issue of the Journal of the ... by air traffic controllers tracks patient data more effectively and ... use of clipboards. Currently there is no standard practice ... the radiology suite, operating rooms, the intensive care unit, inpatient ...
... insulin resistance, study finds , THURSDAY, June 11 (HealthDay ... insulin resistance and lead to a condition known as ... outlined Thursday at the Endocrine Society,s annual meeting in ... risk for diabetes. The same team of researchers was ...
Cached Medicine News:Health News:Swine Flu Now a Pandemic 2Health News:Swine Flu Now a Pandemic 3Health News:Swine Flu Now a Pandemic 4Health News:Swine Flu Now a Pandemic 5Health News:Swine Flu Now a Pandemic 6Health News:Swine Flu Now a Pandemic 7Health News:Swine Flu Now a Pandemic 8Health News:Swine Flu Now a Pandemic 9Health News:Swine Flu Now a Pandemic 10Health News:Swine Flu Now a Pandemic 11Health News:Swine Flu Now a Pandemic 12Health News:Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate, Says Aon Consulting's Radford 2Health News:Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate, Says Aon Consulting's Radford 3Health News:Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate, Says Aon Consulting's Radford 4Health News:Study finds air traffic control tracking method reduces errors in trauma management 2Health News:Nicotine May Help Spur 'Prediabetes' 2
... This programmable system automates the denaturation ... procedures, and provides walk-away convenience for ... cost unit accepts a wide range ... use, and reduces hands-on time by ...
... DiffSpin Slide Spinner for technique independent ... wedge smears.,DiffSpin is a compact, quiet, ... the preparation of uniformly distributed cell ... with a start-up supply of slides ...
... systems deliver pulsed light over one smooth ... spikes (which may damage skin) that other ... sends a chilled water supply through the ... which is cooled to as low as ...
... small, quiet, high-speed centrifuge. It employs a ... results in nearly vibration- free operation. Light ... speed and full breaking in a few ... a simple push-on/ pull-off; transforming the centrifuge ...
Medicine Products: